Generative AI and other technologies are transforming clinical research and trials. Find out how it's done.

The clinical trials sector is risk-averse, heavily regulated, and not often thought of as a technology first-mover. How is Merck changing that perception by using AI to improve insights, innovation, and operations?

Join Steve Odland and guest Jennifer Sheller, senior vice president and head of global clinical trial operations at Merck, to find out how the company is using AI for clinical research and clinical trials, why "human in the loop" remains essential, and how Merck thinks about the ethical, safety, and privacy considerations of digital health.

For more from The Conference Board:

• How AI Can Help Remedy the US Health Care Workforce Crisis

• Health Care Workforce Policy Summit: Insight Summary

• Navigating the Health Care Landscape in 2026